Skip to content
An Initiative of AVAC
Search

Resource Library

The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.

Filter By
Multiple filters can be used at once

Showing results 161 - 170 of 171

Selected Filters:
13 December 2018

OPTIONS Consortium Overview

A two page overview of the OPTIONS consortium. This document describes its mission and objectives, membership and funding structure.

Service Delivery

External Link
12 December 2018

South African Guidelines on the Safe Use of Pre-exposure Prophylaxis in Persons at Risk of Acquiring HIV-1 Infection (2016)

The aim of these guidelines is to explain what PrEP is; outline indications for its use; outline steps for appropriate user selection; provide guidance to monitor and maintain PrEP users.

Normative Guidance/Policies

Document
21 August 2018

Dapivirine Ring Early Introduction Considerations — South Africa Analysis

The OPTIONS Consortium conducted secondary research and interviews with key stakeholders in several countries to understand questions about the ring that could inform demonstration and processes for introducing new biomedical HIV prevention products. South Africa was prioritized for analysis due to the state of the HIV epidemic in the country and experience with ring trials.…

Research

Document
25 July 2018

Factors Influencing Initiation, Continuation & Discontinuation of Oral PrEP at Selected Facilities in South Africa

This South Africa-based study, a collaborative effort between OPTIONS (Wits RHI) and Prevention Market Manager, examined factors affecting clients' decisions to initiate, continue or stop using PrEP. It also assessed service provider knowledge, attitudes and practiced behavior around oral PrEP delivery and examined the effectiveness of oral PrEP marketing and communication.

Community/Advocacy, Demand Creation/Marketing, Research, Service Delivery

Document
1 August 2017

Assessment of Opportunities to Deliver Oral PrEP for Women Through Private Sector Health Care: South Africa research findings

The objective of this research is to support planning by the South African government, international donors, and implementing agencies by providing an overview of the opportunities and considerations for delivering oral PrEP to women through the private sector. This analysis is focused on the delivery of oral PrEP and does not include other areas of…

Financing & Costing, Research, Monitoring & Evaluation

Document
13 July 2017

South Africa PrEP Launch: IEC for Sex Workers Posters

Posters with information, education and communication for sex workers- used in the South Africa PrEP launch.

Community/Advocacy, Demand Creation/Marketing

Document
6 July 2017

IEC for Sex Workers: FAQ brochure

Brochure with information, education and communication for sex workers - used in the South Africa PrEP launch.

Community/Advocacy, Demand Creation/Marketing

Document
21 October 2016

OPTIONS Review and Documentation of M&E Indicators for Oral PrEP

A summary of current monitoring and evaluation of demonstration projects that are delivering Oral PrEP. This overview includes a list of WHO recommended indicators which are also required for reporting under PEPFAR/OGAC.

Monitoring & Evaluation

Document
3 June 2015

MTN-017

Archived from the MTN website before it was taken down. Primary Objectives Compare the safety profiles of Truvada®, daily RG tenofovir 1% gel, and receptive anal intercourse (RAI)-associated RG tenofovir 1% gel Evaluate and compare acceptability of Truvada, daily RG tenofovir 1% gel, and RAI-associated RG tenofovir 1% gel Study Summary MTN-017 was a Phase…

Research

15 February 2015

MTN-003 VOICE

Archived from the MTN website before it was taken down. Primary Objectives Estimate the effectiveness of daily tenofovir 1% gel compared to a vaginal placebo gel, and the effectiveness of oral TDF and oral FTC/TDF compared to an oral placebo in preventing HIV infection among women at risk for sexually transmitted infection (STI) Evaluate the…

Research